![Stephen D. Harrison](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Stephen D. Harrison
Direttore Tecnico/Scientifico/R&S presso Engine Biosciences Pte Ltd.
Profilo
Stephen D.
Harrison is currently the Scientific Director & Senior Vice President at Engine Biosciences Pte Ltd.
He previously held positions as Principal at Chiron Corp., Vice President-Research Biology at Nektar Therapeutics, Vice President-Research at Thios Pharmaceuticals, Inc., Senior Vice President-Research at KAI Pharmaceuticals, Inc., and Chief Scientific Officer & Senior Vice President at Relypsa, Inc. Harrison received his undergraduate, graduate, and doctorate degrees from the University of Cambridge.
Posizioni attive di Stephen D. Harrison
Società | Posizione | Inizio |
---|---|---|
Engine Biosciences Pte Ltd.
![]() Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore. | Direttore Tecnico/Scientifico/R&S | 10/05/2018 |
Precedenti posizioni note di Stephen D. Harrison
Società | Posizione | Fine |
---|---|---|
NEKTAR THERAPEUTICS | Corporate Officer/Principal | - |
RELYPSA INC | Direttore Tecnico/Scientifico/R&S | - |
Thios Pharmaceuticals, Inc.
![]() Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thios Pharmaceuticals, Inc. was engaged in providing researches therapies. The therapies provided by the company target sulfation pathways, which could lead to potential for treatments for inflammation, cancer and other diseases. Thios Pharmaceuticals was located in Oakland, CA. | Direttore Tecnico/Scientifico/R&S | - |
Chiron Corp.
![]() Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | - |
KAI Pharmaceuticals, Inc.
![]() KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Stephen D. Harrison
University of Cambridge | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NEKTAR THERAPEUTICS | Health Technology |
Aziende private | 5 |
---|---|
KAI Pharmaceuticals, Inc.
![]() KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Thios Pharmaceuticals, Inc.
![]() Thios Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thios Pharmaceuticals, Inc. was engaged in providing researches therapies. The therapies provided by the company target sulfation pathways, which could lead to potential for treatments for inflammation, cancer and other diseases. Thios Pharmaceuticals was located in Oakland, CA. | Health Technology |
Chiron Corp.
![]() Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Relypsa, Inc.
![]() Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA. | Health Technology |
Engine Biosciences Pte Ltd.
![]() Engine Biosciences Pte Ltd. BiotechnologyHealth Technology Engine Biosciences Pte Ltd. develops novel combinations of genes and drugs for therapeutic and industrial purposes. The company was founded by Timothy Lu and Jeffrey Lu and is headquartered in Singapore. | Health Technology |
- Borsa valori
- Insiders
- Stephen D. Harrison